Latest news with #OGI
Yahoo
6 days ago
- Business
- Yahoo
Deployment of BVLOS-Capable Drones Expands Market Reach in Large-Scale Oilfield Applications
Growth is driven by the increasing adoption of drones due to their efficiency and cost-effectiveness compared to traditional methods, advancements in sensor technology, and the heightened focus on environmental regulations and safety. Drones equipped with cutting-edge TDLAS, OGI, and LiDAR sensors provide precise and rapid leak detection, enhancing regulatory compliance and environmental stewardship. Drone-based Gas Leak Detection in Oil and Gas Market Dublin, May 30, 2025 (GLOBE NEWSWIRE) -- The "Drone-based Gas Leak Detection in Oil and Gas - Global Strategic Business Report" has been added to global market for Drone-based Gas Leak Detection in Oil and Gas was valued at US$8.2 Billion in 2024 and is projected to reach US$10.6 Billion by 2030, growing at a CAGR of 4.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Drone-based Gas Leak Detection in Oil and Gas market. Why Are Drones Emerging as a Game-Changer in Gas Leak Detection?Drone-based gas leak detection is rapidly transforming monitoring and safety protocols across the oil and gas industry. Traditional ground-based and manned aerial surveillance methods are often time-consuming, expensive, and limited in scope, especially in vast or hazardous environments like offshore rigs, remote pipelines, and gas processing facilities. Drones equipped with advanced sensors - such as tunable diode laser absorption spectroscopy (TDLAS), optical gas imaging (OGI), and LiDAR - offer a cost-effective, rapid, and non-intrusive solution. These UAVs can cover large distances in less time while providing high-resolution spatial data on methane, propane, ethane, and other volatile gases, helping detect minute leaks early before they escalate into safety or environmental ability to fly at low altitudes and hover near high-risk infrastructure allows drones to capture detailed data inaccessible to conventional systems. Moreover, they minimize human exposure to dangerous zones, especially in high-pressure pipelines or flammable environments. In upstream exploration, drones help identify fugitive emissions around drilling operations; in midstream transport, they monitor transmission lines; and in downstream refining, they scan critical storage and processing zones. The precision and frequency of drone inspections also improve regulatory compliance with environmental mandates - such as those from the U.S. EPA, EU Methane Strategy, and Canada's Clean Fuel Regulations - further enhancing their market Key Technologies Are Advancing Drone-Based Detection Systems?The rise of drone-based gas leak detection is fueled by ongoing breakthroughs in miniaturized, high-sensitivity sensor payloads and integrated data analytics platforms. TDLAS systems, for example, can detect methane concentrations as low as parts per billion, while OGI cameras operating in the mid-wave infrared (MWIR) range provide real-time visual feedback on invisible hydrocarbon plumes. Paired with GPS and inertial measurement units (IMUs), these sensors offer geo-tagged leak data that can be mapped and analyzed to identify trends, hotspot areas, and maintenance priorities. Integration of AI and machine learning is further enabling drones to autonomously differentiate between false positives and real threats, thus enhancing detection accuracy and operational platforms and edge computing are making it easier to process and interpret leak data in real-time. Drones can now transmit leak intensity, GPS coordinates, and thermal imaging data instantly to control centers, enabling faster response actions. The addition of LiDAR technology is also enhancing structural modeling and fault prediction by providing 3D terrain and infrastructure mapping. Meanwhile, hybrid UAV designs with extended flight endurance - such as hydrogen fuel cell drones or tethered drones - are overcoming the battery limitations of conventional quadcopters, allowing longer surveillance missions. These technological advances are pushing drone-based leak detection from a pilot-stage innovation to a mainstream industrial Is Driving Market Growth and Commercial Investment?The growth in the drone-based gas leak detection market is driven by several factors related to sensor innovation, end-use expansion, and regulatory compliance needs. One of the primary growth drivers is the development of compact, lightweight gas detection modules compatible with commercial-grade drones. This has made deployment easier for smaller oil and gas operators, expanding the addressable market. Additionally, demand from midstream operators for pipeline monitoring - especially in politically or geographically sensitive areas - is increasing investment in long-range drone surveillance solutions equipped with AI-powered analytics and automated reporting market is also benefiting from the rising integration of UAV operations into enterprise asset management systems and environmental performance platforms. This convergence allows drone-collected data to feed directly into maintenance workflows, emission inventories, and ESG reporting dashboards. Meanwhile, regulatory shifts mandating frequent and verifiable leak detection in regions like North America, the EU, and the Middle East are compelling energy companies to adopt drone technology to avoid fines, improve transparency, and gain public trust. Moreover, the rise of service-based business models - wherein third-party providers offer drone-based detection as a managed service - is lowering adoption barriers and attracting new users. These developments are positioning drone-based gas leak detection as a strategic pillar in modern oil and gas operations, with continued growth expected through the end of the ScopeThe report analyzes the Drone-based Gas Leak Detection in Oil and Gas market, presented in terms of market value (US$ Thousand). The analysis covers the key segments outlined Technology (Fixed Gas Sensors, Open Path Gas Sensors, Portable Gas Sensors, Optical Gas Imaging, Infrared Imaging, UV Imaging, Other Technologies) Drone Type (Fixed-Wing Drones, Multirotor Drones, Hybrid Drones) Gas Type (Methane, Hydrogen Sulfide, Propane, Other Gas Types); Category (Onshore, Offshore) Key Insights: Market Growth: Understand the significant growth trajectory of the Fixed Gas Sensors segment, which is expected to reach US$2.8 Billion by 2030 with a CAGR of a 3.8%. The Open Path Gas Sensors segment is also set to grow at 3.3% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, valued at $2.2 Billion in 2024, and China, forecasted to grow at an impressive 7.8% CAGR to reach $2.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as ABB Ltd., Aeromon, ChampionX, DJI, FEDS Drone-powered Solutions and more. Tariff Impact Analysis: Key Insights for 2025Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments and incorporates forward-looking insights into the market analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and Attributes: Report Attribute Details No. of Pages 473 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $8.2 Billion Forecasted Market Value (USD) by 2030 $10.6 Billion Compound Annual Growth Rate 4.3% Regions Covered Global Key Topics Covered: MARKET OVERVIEW World Market Trajectories Drone-based Gas Leak Detection in Oil and Gas - Global Key Competitors Percentage Market Share in 2025 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E) MARKET TRENDS & DRIVERS Stringent Emission Regulations Drive Adoption of Drone-Based Methane and Gas Leak Detection Technologies Integration of Infrared and Laser Spectroscopy Sensors Enhances Accuracy of UAV-Based Leak Surveys Growing Focus on Environmental Compliance Strengthens Business Case for Autonomous Drone Monitoring Cost Reduction in Pipeline Inspection Operations Spurs Demand for Aerial Leak Detection Drones Expansion of Remote and Hard-to-Reach Oilfields Propels Growth of Drone-Based Surveillance Systems Advancements in AI-Enabled Data Analytics Improve Detection Precision and Reduce False Positives Increased Frequency of ESG Audits Drives Oil Companies to Adopt Real-Time Leak Monitoring Technologies Integration of Cloud Platforms and Edge Computing Enhances Real-Time Gas Leak Reporting Capabilities Rising Incidents of Pipeline Failures Highlight Need for Preventive Aerial Gas Monitoring Solutions Deployment of BVLOS-Capable Drones Expands Market Reach in Large-Scale Oilfield Applications Energy Sectors Push for Digital Transformation Accelerates Adoption of Automated Leak Detection Systems Use of Multispectral Imaging in Drones Strengthens Detection Capabilities in Complex Environments FOCUS ON SELECT PLAYERS Some of the 32 companies featured in this Drone-based Gas Leak Detection in Oil and Gas market report include: Aeromon ChampionX DJI FEDS Drone-powered Solutions Flogistix LaSen, Inc. MFE Inspection Solutions Mile High Drones OSS Enviro Percepto Pergam-Suisse AG RAE Systems (Honeywell) SeekOps Inc. SensorUp Soarability Taurob Terra Drone Corporation Vision Aerial Volatus Aerospace For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Drone-based Gas Leak Detection in Oil and Gas Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Yahoo
13-05-2025
- Business
- Yahoo
Organigram Global Inc (OGI) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion
Gross Sales: Increased 79% year-over-year, surpassing $100 million for the first time in a quarter. Net Revenue: Up 74% year-over-year to $65.6 million. International Sales: Increased 177% to $6.1 million from $2.2 million in the prior-year period. Adjusted Gross Margin: $21.9 million or 33%, compared to $11.6 million or 31% in the prior-year period. Adjusted EBITDA: $4.9 million compared to negative $1 million in the prior-year period. Net Income: $42.5 million compared to a net loss of $27.1 million in Q2 fiscal 2024. Cash Position: Total cash of $83.4 million as of March 31, including both restricted and unrestricted cash. SG&A Costs: Total SG&A costs were $22.4 million, a 10% increase versus the prior period last year. Capital Expenditures: Planned investment of $8 million to $10 million in sustaining capital expenditures during fiscal 2025. Warning! GuruFocus has detected 2 Warning Signs with OGI. Release Date: May 12, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Organigram Global Inc (NASDAQ:OGI) reported a record-breaking quarter by revenue, with gross sales up 79% year-over-year, surpassing $100 million for the first time. The company achieved a leading market share in Canada, particularly in the vape category with a 21.7% share, and maintained strong positions in flower and pre-rolls. International sales increased by 177% year-over-year, driven by strong demand in markets like Germany and Australia. The integration of the Motif acquisition is progressing well, with expected synergies now estimated at $15 million annually, up from the previous $10 million. Organigram Global Inc (NASDAQ:OGI) is expanding its presence in the US hemp-derived THC beverage market, with products now distributed in 10 states and carried by major retailers. Despite the record revenue, the company experienced negative cash flow this quarter, primarily due to working capital investments and the Collective Project acquisition. Margins from the Motif acquisition were lower than the core business, impacting overall adjusted gross margin. The company faces a fragmented and competitive market in Canada, with the top three LPs holding only 27% of total market share. There is potential for price compression in international markets, as value flower is starting to appear in Germany. The US hemp-derived THC beverage market is highly competitive, with many brands and the need for significant investment to drive growth and consumer adoption. Q: Can you provide more details on your international growth outlook for 2025, especially regarding the EU-GMP certification and its impact on capacity allocation between international and domestic markets? A: Beena Goldenberg, CEO: We are balancing demands between domestic and international sales. International sales have higher margins due to the absence of excise taxes, but we aim to maintain our domestic market leadership. We anticipate price compression in international markets, so it's crucial to balance both. We are increasing capacity with projects like the LED upgrade, adding 14,000 kilos of capacity. We expect higher international sales in the latter half of the year, driven by demand in Germany and other markets. Q: What are your expectations for EBITDA margins in the medium term, and what are the key drivers for margin improvement? A: Greg Guyatt, CFO: We have realized about $1.5 million of the $5 million in targeted synergies for this year, mainly in COGS. EBITDA growth will be driven by margin growth, targeting a 40% gross margin in the second half of fiscal 2026, and cost management. As revenue grows, SG&A is not expected to increase materially, allowing for better leverage on the P&L and improved EBITDA margins. Q: Can you explain the negative cash flow this quarter and your cash flow expectations for the rest of the year? A: Greg Guyatt, CFO: The negative cash flow was mainly due to a $6 million investment in the Collective Project acquisition and intentional working capital investment to prepare for strong growth in Q3 and Q4. We expect to be cash flow positive for the full year, with significant cash flow improvements starting in the third quarter. Q: What is your strategy for the US hemp-derived THC market, and when do you expect it to be accretive to margins? A: Beena Goldenberg, CEO: We are in the early stages of expanding the Collective Project brand in the US, focusing on building distribution and consumer awareness. We expect to expand distribution to more states and launch a direct-to-consumer website soon. While we are investing in growth, we anticipate the US market to become more accretive as we scale and gain consumer adoption. Q: What drove the significant increase in international sales, and was it due to new customers or expanded orders from existing partners? A: Beena Goldenberg, CEO: The growth was driven by meeting increased demand from existing customers, not new ones. There is strong demand for high-quality Canadian cannabis, and once a cultivar is established in medical markets, it leads to repeat purchases. We expect further growth with the upcoming EU-GMP certification, which will streamline fulfillment and potentially increase pricing. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
13-05-2025
- Business
- Yahoo
Organigram Global Inc (OGI) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion
Gross Sales: Increased 79% year-over-year, surpassing $100 million for the first time in a quarter. Net Revenue: Up 74% year-over-year to $65.6 million. International Sales: Increased 177% to $6.1 million from $2.2 million in the prior-year period. Adjusted Gross Margin: $21.9 million or 33%, compared to $11.6 million or 31% in the prior-year period. Adjusted EBITDA: $4.9 million compared to negative $1 million in the prior-year period. Net Income: $42.5 million compared to a net loss of $27.1 million in Q2 fiscal 2024. Cash Position: Total cash of $83.4 million as of March 31, including both restricted and unrestricted cash. SG&A Costs: Total SG&A costs were $22.4 million, a 10% increase versus the prior period last year. Capital Expenditures: Planned investment of $8 million to $10 million in sustaining capital expenditures during fiscal 2025. Warning! GuruFocus has detected 2 Warning Signs with OGI. Release Date: May 12, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Organigram Global Inc (NASDAQ:OGI) reported a record-breaking quarter by revenue, with gross sales up 79% year-over-year, surpassing $100 million for the first time. The company achieved a leading market share in Canada, particularly in the vape category with a 21.7% share, and maintained strong positions in flower and pre-rolls. International sales increased by 177% year-over-year, driven by strong demand in markets like Germany and Australia. The integration of the Motif acquisition is progressing well, with expected synergies now estimated at $15 million annually, up from the previous $10 million. Organigram Global Inc (NASDAQ:OGI) is expanding its presence in the US hemp-derived THC beverage market, with products now distributed in 10 states and carried by major retailers. Despite the record revenue, the company experienced negative cash flow this quarter, primarily due to working capital investments and the Collective Project acquisition. Margins from the Motif acquisition were lower than the core business, impacting overall adjusted gross margin. The company faces a fragmented and competitive market in Canada, with the top three LPs holding only 27% of total market share. There is potential for price compression in international markets, as value flower is starting to appear in Germany. The US hemp-derived THC beverage market is highly competitive, with many brands and the need for significant investment to drive growth and consumer adoption. Q: Can you provide more details on your international growth outlook for 2025, especially regarding the EU-GMP certification and its impact on capacity allocation between international and domestic markets? A: Beena Goldenberg, CEO: We are balancing demands between domestic and international sales. International sales have higher margins due to the absence of excise taxes, but we aim to maintain our domestic market leadership. We anticipate price compression in international markets, so it's crucial to balance both. We are increasing capacity with projects like the LED upgrade, adding 14,000 kilos of capacity. We expect higher international sales in the latter half of the year, driven by demand in Germany and other markets. Q: What are your expectations for EBITDA margins in the medium term, and what are the key drivers for margin improvement? A: Greg Guyatt, CFO: We have realized about $1.5 million of the $5 million in targeted synergies for this year, mainly in COGS. EBITDA growth will be driven by margin growth, targeting a 40% gross margin in the second half of fiscal 2026, and cost management. As revenue grows, SG&A is not expected to increase materially, allowing for better leverage on the P&L and improved EBITDA margins. Q: Can you explain the negative cash flow this quarter and your cash flow expectations for the rest of the year? A: Greg Guyatt, CFO: The negative cash flow was mainly due to a $6 million investment in the Collective Project acquisition and intentional working capital investment to prepare for strong growth in Q3 and Q4. We expect to be cash flow positive for the full year, with significant cash flow improvements starting in the third quarter. Q: What is your strategy for the US hemp-derived THC market, and when do you expect it to be accretive to margins? A: Beena Goldenberg, CEO: We are in the early stages of expanding the Collective Project brand in the US, focusing on building distribution and consumer awareness. We expect to expand distribution to more states and launch a direct-to-consumer website soon. While we are investing in growth, we anticipate the US market to become more accretive as we scale and gain consumer adoption. Q: What drove the significant increase in international sales, and was it due to new customers or expanded orders from existing partners? A: Beena Goldenberg, CEO: The growth was driven by meeting increased demand from existing customers, not new ones. There is strong demand for high-quality Canadian cannabis, and once a cultivar is established in medical markets, it leads to repeat purchases. We expect further growth with the upcoming EU-GMP certification, which will streamline fulfillment and potentially increase pricing. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13-05-2025
- Business
- Yahoo
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -66.67%. A quarter ago, it was expected that this cannabis producer would post a loss of $0.03 per share when it actually produced a loss of $0.05, delivering a surprise of -66.67%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. OrganiGram , which belongs to the Zacks Medical - Products industry, posted revenues of $45.69 million for the quarter ended March 2025, beating the Zacks Consensus Estimate by 8.09%. This compares to year-ago revenues of $27.91 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. OrganiGram shares have lost about 26.7% since the beginning of the year versus the S&P 500's decline of -3.8%. While OrganiGram has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for OrganiGram: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.02 on $45.73 million in revenues for the coming quarter and -$0.16 on $166.74 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Products is currently in the bottom 33% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Another stock from the same industry, TriSalus Life Sciences, Inc. (TLSI), has yet to report results for the quarter ended March 2025. This company is expected to post quarterly loss of $0.20 per share in its upcoming report, which represents a year-over-year change of +63%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. TriSalus Life Sciences, Inc.'s revenues are expected to be $9.26 million, up 43.4% from the year-ago quarter. (We are reissuing this article to correct a mistake. The original article, issued on May 12, should no longer be relied upon.) Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Organigram Global Inc. (OGI) : Free Stock Analysis Report TriSalus Life Sciences, Inc. (TLSI) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Market Online
12-05-2025
- Business
- The Market Online
Organigram reports record Q2 fiscal 2025 results
Organigram (TSX:OGI) announced its financial results for its Q2 of fiscal 2025, showing off notable growth across various metrics Gross revenue increased by 79 per cent to $102.8 million, up from $57.4 million in the same period last year Net revenue rose by 74 per cent to $65.6 million, compared to $37.6 million in the prior year period Organigram stock (TSX:OGI) last traded at C$1.64 Organigram (TSX:OGI) announced its financial results for its Q2 of fiscal 2025, showing off notable growth across various metrics. Financial highlights Gross revenue: Increased by 79 per cent to $102.8 million, up from $57.4 million in the same period last year. Increased by 79 per cent to $102.8 million, up from $57.4 million in the same period last year. Net revenue: Rose by 74 per cent to $65.6 million, compared to $37.6 million in the prior year period. Rose by 74 per cent to $65.6 million, compared to $37.6 million in the prior year period. International revenue: Surged by 177 per cent to $6.1 million, up from $2.2 million year-over-year. Surged by 177 per cent to $6.1 million, up from $2.2 million year-over-year. Adjusted gross margin: Improved to $21.9 million or 33 per cent, from $11.6 million or 31 per cent in the same period last year. Improved to $21.9 million or 33 per cent, from $11.6 million or 31 per cent in the same period last year. Adjusted EBITDA: Jumped to $4.9 million, a significant turnaround from $(1.0) million in the previous year. Jumped to $4.9 million, a significant turnaround from $(1.0) million in the previous year. Cash position: The company maintains a robust cash position of approximately $83.4 million with negligible debt. Operational achievements Market leadership: Organigram continues to hold the #1 market share position in Canada, leading in categories such as vapes, pre-rolls, milled flower, hash, and pure CBD gummies. The company is also ranked #3 in edibles and dried flower. Organigram continues to hold the #1 market share position in Canada, leading in categories such as vapes, pre-rolls, milled flower, hash, and pure CBD gummies. The company is also ranked #3 in edibles and dried flower. Motif integration: The integration of Motif is now expected to exceed initial estimates, providing approximately $15 million in annual cost synergies, up from the original estimate of $10 million. The integration of Motif is now expected to exceed initial estimates, providing approximately $15 million in annual cost synergies, up from the original estimate of $10 million. Acquisition of Collective Project Ltd.: This acquisition marks Organigram's entry into the burgeoning U.S. and Canadian beverage markets, with current distribution in 10 states and six provinces. International expansion Organigram achieved $6.1 million in international sales during Q2 Fiscal 2025 and anticipates further growth in the second half of the fiscal year. The company has established supply agreements with partners in Germany, the U.K., and Australia, and is exploring additional global partnership opportunities. Organigram's CEO, Beena Goldenberg expressed optimism about the company's trajectory, highlighting the strong financial performance and strategic initiatives that position the company for sustained growth in the competitive cannabis market. 'We are unlocking meaningful global growth potential — from increasing sales into key international markets like Germany, to our entrance into the U.S. hemp-derived beverage space,' she said in a media release. 'We expect this momentum to continue as we further strengthen our leadership in Canada and head into the seasonally stronger back half of the year.' About Organigram Organigram is a licensed Canadian producer of cannabis, cannabis-derived products and cannabis infused edibles. Its brand portfolio includes Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram stock (TSX:OGI) last traded at C$1.64 and was up 3.14 per cent last week, but down 31.67 per cent since this time last year. Join the discussion: Find out what everybody's saying about this cannabis stock in Canada on the Organigram Holdings Inc. Bullboard and check out Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
